HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Skin cancer in patients with chronic radiation dermatitis.

Abstract
The cases of 76 patients with chronic radiation dermatitis resulting from low-dose ionizing radiation for benign disease were reviewed retrospectively for risk factors leading to the development of neoplasia. The patients were studied with respect to original hair color, eye color, sun reactive skin type, benign disease treated, area treated, age at treatment, and age at development of first skin cancer. Analysis of data showed 37% of patients had sun-reactive skin type I, 27% had type II, and 36% had type III. Types IV through VI were not represented. There appeared to be an overrepresentation of types I and II. Increased melanin pigmentation may therefore be either directly or indirectly protective against the development of skin cancers in patients who have received low-dose superficial ionizing radiation for benign disease. The sun-reactive skin type of patients with chronic radiation dermatitis may be used as a predictor of skin cancer risk when the total dose of ionizing radiation is not known.
AuthorsM M Davis, C W Hanke, T W Zollinger, J F Montebello, N B Hornback, A L Norins
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 20 Issue 4 Pg. 608-16 (Apr 1989) ISSN: 0190-9622 [Print] United States
PMID2715408 (Publication Type: Journal Article)
Topics
  • Carcinoma, Basal Cell (etiology)
  • Carcinoma, Squamous Cell (etiology)
  • Female
  • Humans
  • Male
  • Photosensitivity Disorders (complications)
  • Radiation Injuries (complications)
  • Risk Factors
  • Skin (radiation effects)
  • Skin Diseases (radiotherapy)
  • Skin Neoplasms (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: